Insilico Medicine reaches preclinical milestone in MASH drug discovery
Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, recently achieved preclinical milestone in its collaboration with Therasid Bioscience, a South Korean based…
Read More...
Read More...